Data as of Apr 17
| -0.08 / -1.49%|
The 8 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 12.00, with a high estimate of 16.00 and a low estimate of 9.00. The median estimate represents a +126.42% increase from the last price of 5.30.
The current consensus among 8 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.